期刊文献+

托拉塞米院外维持治疗慢性心力衰竭水肿的疗效观察 被引量:4

下载PDF
导出
摘要 目的观察慢性稳定充血性心力衰竭患者院外服用新型袢利尿剂托拉塞米的利尿效果和安全性。方法将58例因心衰病情加重住院患者治疗好转出院后,根据服用利尿剂不同随机分成两组,分别服用托拉塞米和呋塞米,观察8周内的利尿效果和不良反应。结果托拉塞米组增加药量需求小(P<0.05),水肿复发时间短(P<0.05),再次住院比例低(P<0.05),低钾血症、高尿酸血症发生率低(P<0.05)。结论慢性心衰患者院外服用托拉塞米较呋塞米更有优势。
作者 高英
出处 《广西医学》 CAS 2007年第5期683-684,共2页 Guangxi Medical Journal
  • 相关文献

参考文献6

  • 1慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2414
  • 2Fowler SF,Murray KM.Torsemide:a new loop diuretic[J].Am J Health Syst Pharm,1995,52(16):1 771-1 780;1 814-1 815.
  • 3Kido H,Ohtaki Y.Torasemide (LUPRAC):a review of its pharmacological and clinical profile[J].Nippon Yakurigaku Zasshi,2001,118(2):97-105.
  • 4Spannheimer A,Muller K,Falkenstein P,et al.Long-term diuretic treatment in heart failure:are there differences between furosemide and torasemide?[J].Schweiz Rundsch Med Prax,2002,91(37):1 467-1 475.
  • 5Kasama S,Toyama T,Hatori T,et al.Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure[J].Heart,2006,92(10):1 434-1 440.
  • 6李一石,华潞,陈君柱,黄德嘉,黄洁,何建国,姚康宝,张健,蒋文,汪芳,苏绮,刘晗,成小如,康健,张阴凤.托拉塞米、呋噻米治疗慢性心力衰竭水肿的疗效和安全性比较研究[J].中国循环杂志,2004,19(4):290-293. 被引量:22

二级参考文献10

  • 1Blose JS, Adams KFJr, Patterson JH. Torsemide:a pyridine-sulfonylurea loop diuretic. Ann Pharmacother 1995 , 29(4) :396-402.
  • 2Hunt Baker DW,Chin MH,et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001, 11,2996-3007.
  • 3Frieder HA, Buckley MM-T. Torasemide-a review of its pharmacology,properties and therapeutic potential. Drugs, 1991,41:81-103.
  • 4Brater DC. Clinical pharmacology of loop diuretics. Drugs, 1991,41:14-22.
  • 5Stauch M, Stiehl L. Controlled, double-blind clinical trial on the efficacy and tolerance of torasemide in comparison with furosemide in patients with congestive heart failure-a multicenter study. In:Kruck F, Mutschler E, Knauf H, eds. Torasemide: clinica
  • 6Sarah F, Fowler Kim M, Murray. Torsemide:A new loop diruetic. Am J Health-Syst Pharm 1995 ,52 ( 15 ): 1771-1780.
  • 7Cosin J, Diez J, TORIC investigators. Torasemide in chronic heart failuro:results of the TORIC study. Eur J Heart Fail 2002,4(4) :507.
  • 8Goodfriend TL, Ball DL, Oelkers W, et al. Torsemide inhibits aldosterone secretion in vitro. Life Sci, 1998,63 ( 3 ): PL45-50.
  • 9Kido H, Ohtaki Y. Torasemide (LUPRAC) :a review of its pharmacological and clinical profile. Nippon Yakurigaku Zasshi,2001,118( 2 ):97-105.
  • 10Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999

共引文献2433

同被引文献21

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部